VRTX Vertex Pharmaceuticals | 10/8/2026 | Boost Price Target | $507.16 | $576.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 10/8/2026 | Boost Price Target | $112.27 | $114.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 10/8/2026 | Lower Price Target | $17.40 | $17.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 10/8/2026 | Boost Price Target | $730.07 | $810.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 10/8/2026 | Boost Price Target | $145.57 | $126.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 10/8/2026 | Lower Price Target | $219.48 | $256.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 10/8/2026 | Lower Price Target | $19.46 | $36.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 10/7/2026 | Lower Price Target | $63.70 | $75.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 9/29/2026 | Reiterated Rating | $752.25 | $737.00 | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 9/24/2026 | Reiterated Rating | $5.50 | $6.00 | Sector Perform | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
LKFT Lakefront Biotherapeutics American Depositary Shares | 9/23/2026 | Upgrade | $30.19 | $45.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 9/22/2026 | Reiterated Rating | $125.09 | $109.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 9/18/2026 | Lower Price Target | $41.17 | $70.00 | Outperform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 9/11/2026 | Reiterated Rating | $38.60 | $66.00 | Outperform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 9/10/2026 | Downgrade | $8.81 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
EVMN Evommune | 9/9/2026 | Lower Price Target | $11.25 | $21.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 9/8/2026 | Reiterated Rating | $156.07 | $198.00 | Outperform | $0.00 00.00% ROI | |
ATTO Attovia Therapeutics | 8/31/2026 | Initiated Coverage | $20.70 | $45.00 | Outperform | $0.00 00.00% ROI | |
ATTO Attovia Therapeutics | 8/30/2026 | Upgrade | $21.40 | | Moderate Buy | $0.00 00.00% ROI | |
BIIB Biogen | 8/25/2026 | Boost Price Target | $218.12 | $260.00 | Outperform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 8/13/2026 | Boost Price Target | $44.46 | $66.00 | Outperform | $0.00 00.00% ROI | |
PHVS Pharvaris | 8/13/2026 | Boost Price Target | $34.56 | $52.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 8/11/2026 | Lower Price Target | $27.96 | $26.00 | Sector Perform | $0.00 00.00% ROI | |
NRIX Nurix Therapeutics | 8/10/2026 | Boost Price Target | $25.57 | $36.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 8/7/2026 | Lower Price Target | $63.64 | $81.00 | Outperform | $0.00 00.00% ROI | |
EVMN Evommune | 8/7/2026 | Lower Price Target | $14.20 | $29.00 | Outperform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 8/6/2026 | Lower Price Target | $9.42 | $13.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 8/5/2026 | Boost Price Target | $28.32 | $37.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 8/5/2026 | Boost Price Target | $130.70 | $123.00 | Sector Perform | $0.00 00.00% ROI | |
CTNM Contineum Therapeutics | 7/31/2026 | Boost Price Target | $15.27 | $23.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 7/31/2026 | Boost Price Target | $763.17 | $737.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/31/2026 | Boost Price Target | $166.77 | $198.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 7/30/2026 | Lower Price Target | $205.31 | $240.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 7/29/2026 | Boost Price Target | $127.16 | $109.00 | Sector Perform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 7/13/2026 | Downgrade | $119.35 | $115.00 | Sector Perform | $0.00 00.00% ROI | |
NMRA Neumora Therapeutics | 7/13/2026 | Lower Price Target | $1.62 | $5.00 | Outperform | $0.00 00.00% ROI | |
NRIX Nurix Therapeutics | 7/10/2026 | Boost Price Target | $23.97 | $33.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 7/7/2026 | Boost Price Target | $529.59 | $570.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 7/7/2026 | Boost Price Target | $85.44 | $85.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 7/7/2026 | Boost Price Target | $115.62 | $99.00 | Sector Perform | $0.00 00.00% ROI | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
BIIB Biogen | 7/7/2026 | Boost Price Target | $208.46 | $242.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 7/7/2026 | Boost Price Target | $25.77 | $36.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 7/7/2026 | Lower Price Target | $668.88 | $696.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/7/2026 | Boost Price Target | $178.11 | $195.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 7/7/2026 | Lower Price Target | $134.71 | $120.00 | Sector Perform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 7/7/2026 | Boost Price Target | $10.19 | $14.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/8/2026 | Reiterated Rating | $129.17 | | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 6/8/2026 | Boost Price Target | $86.92 | $97.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/1/2026 | Reiterated Rating | $134.43 | $122.00 | Overweight | $0.00 00.00% ROI | |
GILD Gilead Sciences | 6/1/2026 | Upgrade | $131.10 | | Moderate Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 5/29/2026 | Boost Price Target | $157.47 | $183.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 5/27/2026 | Boost Price Target | $193.08 | $227.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 5/18/2026 | Lower Price Target | $623.32 | $707.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 5/8/2026 | Lower Price Target | $130.55 | $122.00 | Sector Perform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 5/8/2026 | Boost Price Target | $79.08 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/8/2026 | Boost Price Target | $55.89 | $82.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 5/6/2026 | Boost Price Target | $144.90 | $180.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 5/5/2026 | Boost Price Target | $429.85 | $543.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 4/30/2026 | Boost Price Target | $191.32 | $222.00 | Outperform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 4/30/2026 | Lower Price Target | $707.09 | $762.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 4/29/2026 | Boost Price Target | $191.58 | $222.00 | Outperform | $0.00 00.00% ROI | |
DMRA Damora Therapeutics, Inc. Common Stock | 4/24/2026 | Initiated Coverage | $25.42 | $40.00 | Outperform | $0.00 00.00% ROI | |
DMRA Damora Therapeutics, Inc. Common Stock | 4/23/2026 | Upgrade | $24.75 | | Moderate Buy | $0.00 00.00% ROI | |
EVMN Evommune | 4/10/2026 | Reiterated Rating | $27.56 | $48.00 | Outperform | $0.00 00.00% ROI | |
PHVS Pharvaris | 4/6/2026 | Lower Price Target | $28.56 | $51.00 | Outperform | $0.00 00.00% ROI | |
PHVS Pharvaris | 3/9/2026 | Initiated Coverage | $26.63 | $52.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 3/2/2026 | Lower Price Target | $70.92 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 3/2/2026 | Downgrade | $12.49 | $6.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 3/2/2026 | Boost Price Target | $784.09 | $765.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/2/2026 | Boost Price Target | $17.69 | $13.00 | Sector Perform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 2/26/2026 | Reiterated Rating | $91.56 | $108.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/26/2026 | Lower Price Target | $24.82 | $30.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 2/24/2026 | Boost Price Target | $34.36 | $33.00 | Sector Perform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 2/20/2026 | Lower Price Target | $69.90 | $82.00 | Sector Perform | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/20/2026 | Boost Price Target | $17.86 | $12.00 | Sector Perform | $0.00 00.00% ROI | |
PRTA Prothena | 2/20/2026 | Boost Price Target | $8.83 | $12.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/13/2026 | Lower Price Target | $496.69 | $541.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/12/2026 | Lower Price Target | $126.01 | $177.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 2/11/2026 | Boost Price Target | $156.39 | $118.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 2/11/2026 | Lower Price Target | $98.59 | $92.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 2/9/2026 | Boost Price Target | $201.18 | $233.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/3/2026 | Lower Price Target | $26.13 | $31.00 | Outperform | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 1/30/2026 | Lower Price Target | $6.44 | $13.00 | Outperform | $0.00 00.00% ROI | |
NRIX Nurix Therapeutics | 1/29/2026 | Boost Price Target | $17.60 | $30.00 | Outperform | $0.00 00.00% ROI | |
GHRS GH Research | 1/23/2026 | Boost Price Target | $16.46 | $40.00 | Outperform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 1/23/2026 | Boost Price Target | $17.29 | $36.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 1/22/2026 | Downgrade | $81.91 | $83.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 1/22/2026 | Upgrade | $461.14 | $546.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 1/20/2026 | Boost Price Target | $124.91 | $103.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 1/13/2026 | Reiterated Rating | $178.30 | | Outperform | $0.00 00.00% ROI | |
My top 3 AI picks for the next decade (Ad) Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005.
Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade. Click here to get all three AI stock names from Alexander Green |
GILD Gilead Sciences | 1/8/2026 | Lower Price Target | $121.35 | $100.00 | Sector Perform | $0.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 1/8/2026 | Boost Price Target | $21.31 | $18.00 | Sector Perform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 1/6/2026 | Reiterated Rating | $78.59 | | Outperform | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 12/16/2025 | Boost Price Target | $85.68 | $103.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 12/8/2025 | Boost Price Target | $159.46 | $180.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 12/1/2025 | Downgrade | $85.99 | $91.00 | Sector Perform | $0.00 00.00% ROI | |
NMRA Neumora Therapeutics | 12/1/2025 | Upgrade | $2.26 | $7.00 | Outperform | $0.00 00.00% ROI | |
SION Sionna Therapeutics | 12/1/2025 | Reiterated Rating | $43.57 | $24.00 | Underperform | $0.00 00.00% ROI | |
CTNM Contineum Therapeutics | 11/21/2025 | Lower Price Target | $11.08 | $22.00 | Outperform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 11/17/2025 | Downgrade | $217.78 | | Sector Perform | $0.00 00.00% ROI | |
AARD Aardvark Therapeutics | 11/14/2025 | Lower Price Target | $10.86 | $18.00 | Outperform | $0.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 11/13/2025 | Lower Price Target | $11.09 | $53.00 | Outperform | $0.00 00.00% ROI | |
PRTA Prothena | 11/7/2025 | Boost Price Target | $10.15 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
DFTX Definium Therapeutics | 11/7/2025 | Lower Price Target | $11.26 | $20.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 11/7/2025 | Boost Price Target | $31.38 | $32.00 | Sector Perform | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 11/7/2025 | Boost Price Target | $99.95 | $145.00 | Outperform | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 11/6/2025 | Lower Price Target | $21.35 | $32.00 | Outperform | $0.00 00.00% ROI | |
PTCT PTC Therapeutics | 11/5/2025 | Boost Price Target | $72.90 | $82.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 11/4/2025 | Boost Price Target | $39.54 | $58.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 11/4/2025 | Lower Price Target | $430.41 | $415.00 | Sector Perform | $0.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 11/4/2025 | Lower Price Target | $5.66 | $19.00 | Outperform | $0.00 00.00% ROI | |
APGE Apogee Therapeutics | 11/3/2025 | Boost Price Target | $57.13 | $70.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 10/31/2025 | Lower Price Target | $149.61 | $210.00 | Outperform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 10/31/2025 | Boost Price Target | $120.73 | $105.00 | Sector Perform | $0.00 00.00% ROI | |
INCY Incyte | 10/29/2025 | Boost Price Target | $89.19 | $84.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 10/29/2025 | Boost Price Target | $654.96 | $708.00 | Sector Perform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 10/29/2025 | Boost Price Target | $139.82 | $160.00 | Outperform | $0.00 00.00% ROI | |
LKFT Lakefront Biotherapeutics American Depositary Shares | 10/22/2025 | Boost Price Target | $32.33 | $28.00 | Sector Perform | $0.00 00.00% ROI | |
BIIB Biogen | 10/8/2025 | Lower Price Target | $152.21 | $217.00 | Outperform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 10/8/2025 | Boost Price Target | $116.78 | $100.00 | Sector Perform | $000.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 10/8/2025 | Boost Price Target | $24.02 | $16.00 | Sector Perform | $00.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 9/29/2025 | Reiterated Rating | $6.86 | $10.00 | Sector Perform | $00.00 00.00% ROI | |
APGE Apogee Therapeutics | 9/25/2025 | Initiated Coverage | $38.42 | $60.00 | Outperform | $000.00 00.00% ROI | |
CDTX Cidara Therapeutics | 9/24/2025 | Set Price Target | $88.16 | $137.00 | Outperform | $0.00 00.00% ROI | |
INCY Incyte | 9/24/2025 | Boost Price Target | $84.54 | $81.00 | Sector Perform | $000.00 00.00% ROI | |
KYMR Kymera Therapeutics | 9/16/2025 | Initiated Coverage | $47.28 | $70.00 | Outperform | $000.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 9/5/2025 | Boost Price Target | $143.76 | $149.00 | Outperform | $000.00 00.00% ROI | |
SION Sionna Therapeutics | 9/3/2025 | Initiated Coverage | $25.39 | $22.00 | Sector Perform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 9/2/2025 | Reiterated Rating | $39.12 | $55.00 | Outperform | $00.00 00.00% ROI | |
AARD Aardvark Therapeutics | 8/14/2025 | Lower Price Target | $11.44 | $19.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 8/12/2025 | Lower Price Target | $36.96 | $55.00 | Outperform | $00.00 00.00% ROI | |
PTCT PTC Therapeutics | 8/8/2025 | Reiterated Rating | $46.87 | $63.00 | Outperform | $00.00 00.00% ROI | |
ETNB 89BIO | 8/8/2025 | Lower Price Target | $8.92 | $11.00 | Sector Perform | $0.00 00.00% ROI | |
GILD Gilead Sciences | 8/8/2025 | Boost Price Target | $119.21 | $98.00 | Sector Perform | $000.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 8/7/2025 | Boost Price Target | $23.84 | $40.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 8/5/2025 | Lower Price Target | $389.93 | $405.00 | Sector Perform | $000.00 00.00% ROI | |
PRTA Prothena | 8/5/2025 | Lower Price Target | $7.28 | $10.00 | Sector Perform | $0.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 8/4/2025 | Boost Price Target | $569.71 | $695.00 | Sector Perform | $000.00 00.00% ROI | |
BIIB Biogen | 8/1/2025 | Boost Price Target | $126.28 | $219.00 | Outperform | $000.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 7/31/2025 | Lower Price Target | $129.41 | $144.00 | Outperform | $000.00 00.00% ROI | |
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
INCY Incyte | 7/30/2025 | Boost Price Target | $77.88 | $72.00 | Sector Perform | $000.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 7/17/2025 | Lower Price Target | $21.46 | $23.00 | Sector Perform | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 6/30/2025 | Reiterated Rating | $9.23 | $13.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 6/25/2025 | Set Price Target | $126.16 | $213.00 | Outperform | $000.00 00.00% ROI | |
CDTX Cidara Therapeutics | 6/24/2025 | Upgrade | $49.86 | $75.00 | Moderate Buy | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 6/23/2025 | Boost Price Target | $22.12 | $38.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 6/17/2025 | Lower Price Target | $448.47 | $420.00 | Sector Perform | $000.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 5/27/2025 | Reiterated Rating | $599.20 | $662.00 | Sector Perform | $000.00 00.00% ROI | |
CTNM Contineum Therapeutics | 5/15/2025 | Reiterated Rating | $3.72 | $31.00 | Outperform | $00.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 5/13/2025 | Lower Price Target | $5.40 | $33.00 | Outperform | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/13/2025 | Lower Price Target | $29.93 | $55.00 | Outperform | $00.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 5/7/2025 | Lower Price Target | $6.34 | $58.00 | Outperform | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 5/6/2025 | Boost Price Target | $434.64 | $423.00 | Sector Perform | $000.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 5/6/2025 | Reiterated Rating | $10.40 | $13.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 5/2/2025 | Lower Price Target | $122.38 | $205.00 | Outperform | $000.00 00.00% ROI | |
INCY Incyte | 4/30/2025 | Boost Price Target | $61.11 | $67.00 | Sector Perform | $00.00 00.00% ROI | |
REGN Regeneron Pharmaceuticals | 4/30/2025 | Lower Price Target | $586.51 | $943.00 | Outperform | $000.00 00.00% ROI | |
LEGN Legend Biotech | 4/22/2025 | Reiterated Rating | $33.48 | $84.00 | Outperform | $00.00 00.00% ROI | |
BIIB Biogen | 4/22/2025 | Boost Price Target | $117.63 | $225.00 | Outperform | $000.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 4/14/2025 | Upgrade | $90.87 | $137.00 | Outperform | $000.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 4/11/2025 | Reiterated Rating | $6.55 | $11.00 | Outperform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 4/1/2025 | Boost Price Target | $487.06 | $420.00 | Sector Perform | $000.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 3/31/2025 | Downgrade | $70.41 | $87.00 | Sector Perform | $00.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 3/18/2025 | Initiated Coverage | $38.67 | $67.00 | Outperform | $00.00 00.00% ROI | |
AARD Aardvark Therapeutics | 3/10/2025 | Initiated Coverage | $10.13 | $21.00 | Outperform | $0.00 00.00% ROI | |
GHRS GH Research | 3/7/2025 | Initiated Coverage | $10.55 | $31.00 | Outperform | $00.00 00.00% ROI | |
SRPT Sarepta Therapeutics | 2/27/2025 | Lower Price Target | $107.24 | $161.00 | Outperform | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 2/25/2025 | Reiterated Rating | $8.11 | $11.00 | Outperform | $0.00 00.00% ROI | |
PRTA Prothena | 2/21/2025 | Lower Price Target | $15.61 | $20.00 | Sector Perform | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/20/2025 | Boost Price Target | $475.68 | $408.00 | Sector Perform | $000.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 2/20/2025 | Reiterated Rating | $9.41 | $45.00 | Outperform | $0.00 00.00% ROI | |
BIIB Biogen | 2/13/2025 | Lower Price Target | $135.56 | $225.00 | Outperform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 2/12/2025 | Boost Price Target | $103.52 | $90.00 | Sector Perform | $000.00 00.00% ROI | |
INCY Incyte | 2/11/2025 | Lower Price Target | $68.30 | $68.00 | Sector Perform | $000.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/11/2025 | Boost Price Target | $459.15 | $407.00 | Sector Perform | $000.00 00.00% ROI | |
PLRX Pliant Therapeutics | 2/10/2025 | Downgrade | $7.79 | $4.00 | Sector Perform | $0.00 00.00% ROI | |
KPTI Karyopharm Therapeutics | 2/10/2025 | Reiterated Rating | $9.77 | $45.00 | Outperform | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/7/2025 | Lower Price Target | $122.00 | $148.00 | Sector Perform | $000.00 00.00% ROI | |
GILD Gilead Sciences | 2/3/2025 | Reiterated Rating | $99.12 | $84.00 | Sector Perform | $000.00 00.00% ROI | |
AXSM Axsome Therapeutics | 1/29/2025 | Reiterated Rating | $104.53 | $139.00 | Outperform | $000.00 00.00% ROI | |